Director at CONMED (CNMD) receives grant of 5,603 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Martin Celine Christine reported acquisition or exercise transactions in this Form 4 filing.

CONMED Corp director Celine Christine Martin received a grant of restricted stock units as equity compensation. She was awarded 5,603 RSUs tied to CONMED common stock at a price of $0.00 per unit. Following this grant, her reported holdings of this RSU award total 5,603 units.

Each RSU represents a contingent right to receive one share of CONMED common stock under the company’s 2025 Long-Term Incentive Plan. The RSUs generally vest 100% after one year, meaning she will receive the underlying shares if vesting conditions are met and the award does not expire earlier.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Martin Celine Christine

Role null

Type	Security	Shares	Price	Value
Grant/Award	RSUs (Restricted Stock Units)	5,603	$0.00	--

Holdings After Transaction: RSUs (Restricted Stock Units) — 5,603 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 5,603 units Grant price per RSU: $0.00 per unit RSU holdings after grant: 5,603 units +3 more

6 metrics

RSUs granted 5,603 units Grant of restricted stock units on 2026-07-01

Grant price per RSU $0.00 per unit Compensation award, not market purchase

RSU holdings after grant 5,603 units Total RSUs reported following transaction

RSU vesting schedule 100% after one year Vesting terms under 2025 Long-Term Incentive Plan

RSU expiration date 2036-07-01 Expiration of RSU award term

Underlying shares 5,603 common shares One share of common stock per RSU

Key Terms

Restricted Stock Units, contingent right, Long-Term Incentive Plan, vesting

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of common stock"

Long-Term Incentive Plan financial

"subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan"

A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.

vesting financial

"with the RSUs generally vesting 100% after a one year period"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 05:15 PM Accepted by SEC EDGAR 07/02/2026 - 05:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Martin Celine Christine

(Last)

(First)

(Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO

FLORIDA

33773

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
RSUs (Restricted Stock Units)	$0	07/01/2026		A		5,603		07/01/2027⁽¹⁾	07/01/2036	Common Stock	5,603	$0	5,603	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

	/s/ Thomas Fistek for Celine Christine Martin by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did CONMED (CNMD) director Celine Christine Martin report in this Form 4?

She reported receiving a grant of 5,603 restricted stock units as equity compensation. These RSUs relate to CONMED common stock and were issued at $0.00 per unit, reflecting a compensation award rather than a market purchase or sale.

How many CONMED (CNMD) RSUs were granted to the director in this filing?

The filing shows a grant of 5,603 restricted stock units. After the transaction, her reported holdings for this RSU award total 5,603 units, each representing a contingent right to receive one share of CONMED common stock if vesting conditions are satisfied.

What are the key terms of the 5,603 CONMED (CNMD) RSUs granted?

Each RSU represents a contingent right to receive one CONMED common share, par value $0.01. The RSUs generally vest 100% after one year under the company’s 2025 Long-Term Incentive Plan, subject to its terms and any applicable conditions.

Is the CONMED (CNMD) RSU grant to the director a market purchase or sale?

No, the RSU grant is classified as a grant, award, or other acquisition under code A. The 5,603 units were issued at $0.00 per unit as compensation, not bought or sold on the open market, and will convert to shares if they fully vest.

When do the granted CONMED (CNMD) RSUs vest and expire?

The RSUs generally vest 100% after a one-year period from the grant date. The instrument carries an expiration date in 2036, providing a long window for vesting and settlement, subject to the company’s 2025 Long-Term Incentive Plan terms.